LINC02481: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC02481

NCBI ID: G339988

LINC02481

Other Name(s): long intergenic non-protein coding RNA 2481 | LINC002481 | Long intergenic non-protein coding RNA 2481

LINC02481: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC02481 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its unique 2481-base length and its absence of any protein sequences. LINC02481 is a highly conserved gene that has been annotated with various functions, including regulation of cell adhesion, stem cell maintenance, and tissue homeostasis.

Drug Target Potential

The potential drug targets for LINC02481 are numerous and varied. Its unique structure and conservation across different organisms make it an attractive target for drug development due to its potential to modulate various cellular processes.

One potential mechanism by which LINC02481 could be a drug target is its role in cell adhesion. LINC02481 has been shown to play a critical role in the regulation of cell-cell adhesion, which is a critical aspect of tissue repair and regeneration. It is known to interact with various proteins, including E-cadherin, a protein that is involved in cell-cell adhesion. Therefore, small molecules that can modulate E-cadherin activity could potentially be used as LINC02481 drug targets.

Another potential mechanism by which LINC02481 could be a drug target is its role in stem cell maintenance. LINC02481 has been shown to be involved in the regulation of stem cell self-renewal and differentiation. It is known to interact with various proteins, including Sox2, a protein that is involved in stem cell proliferation and differentiation. Therefore, small molecules that can modulate Sox2 activity could potentially be used as LINC02481 drug targets.

In addition to its potential as a drug target, LINC02481 has also been identified as a potential biomarker. Its unique structure and conservation across different organisms make it an attractive target for biomarker development. By using techniques such as RNA sequencing and bioinformatics analysis, researchers have been able to identify differentially expressed genes in various organisms that contain LINC02481. These genes have been shown to be involved in various biological processes, including cell adhesion, stem cell maintenance, and tissue homeostasis. Therefore, LINC02481 has the potential to serve as a valuable biomarker for various diseases.

Conclusion

LINC02481 is a long non-coding RNA that has been identified in various organisms, including humans. Its unique structure and conservation across different organisms make it an attractive target for drug development and biomarker development. Its potential as a drug target is due to its role in cell adhesion and its potential as a biomarker is due to its unique structure and conservation across different organisms. Further research is needed to fully understand the functions of LINC02481 and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2481

The "LINC02481 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02481 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets